Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists

  • Hope S. Rugo
  • , Aditya Bardia
  • , William J. Gradishar
  • , Erika P. Hamilton
  • , Sara A. Hurvitz
  • , Komal Jhaveri
  • , Reshma Mahtani
  • , Sara M. Tolaney

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number104485
JournalBreast
Volume82
DOIs
StatePublished - Aug 2025

ASJC Scopus Subject Areas

  • Surgery
  • Oncology
  • Cancer Research

Keywords

  • Biomarker testing
  • Hormone receptor
  • Human epidermal growth factor receptor 2
  • Metastatic breast cancer
  • Practice guidelines
  • Side effects
  • Treatment patterns

Cite this